GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.66 $159.34 Wednesday, 17th Apr 2024 ALNY stock ended at $145.32. This is 0.95% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 1.58% from a day low at $145.19 to a day high of $147.49.
90 days $143.52 $191.72
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2023-09-12 $204.24 $212.08 $202.87 $211.65 765 145
2023-09-11 $201.57 $204.65 $196.67 $203.72 547 836
2023-09-08 $201.25 $205.50 $200.52 $201.43 621 779
2023-09-07 $201.14 $203.79 $200.18 $201.10 487 703
2023-09-06 $201.50 $201.76 $197.03 $201.45 362 304
2023-09-05 $200.83 $204.45 $199.30 $200.34 436 264
2023-09-01 $199.14 $204.48 $199.14 $201.17 480 901
2023-08-31 $197.50 $200.76 $197.16 $197.82 428 841
2023-08-30 $194.46 $198.34 $194.46 $197.16 310 940
2023-08-29 $191.67 $195.70 $190.97 $194.46 368 247
2023-08-28 $189.99 $192.72 $189.76 $191.66 261 559
2023-08-25 $186.55 $190.49 $186.39 $189.26 191 322
2023-08-24 $189.72 $190.32 $183.73 $186.77 349 547
2023-08-23 $190.40 $192.39 $189.10 $190.38 262 162
2023-08-22 $189.13 $190.30 $187.62 $189.38 411 929
2023-08-21 $186.70 $189.44 $183.41 $188.73 329 358
2023-08-18 $182.19 $186.20 $181.87 $186.03 358 074
2023-08-17 $183.13 $185.40 $182.41 $183.89 389 298
2023-08-16 $179.35 $182.96 $179.00 $182.43 355 903
2023-08-15 $180.00 $181.67 $178.64 $180.13 359 810
2023-08-14 $184.41 $184.41 $180.76 $181.35 648 307
2023-08-11 $184.11 $187.45 $184.11 $185.79 350 871
2023-08-10 $188.02 $189.54 $184.99 $185.03 318 773
2023-08-09 $186.19 $186.67 $184.15 $186.36 367 471
2023-08-08 $184.54 $186.90 $182.72 $184.84 487 244
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT